Design and Synthesis of NTQ1062, a new Akt Inhibitor Clinical Candidate

Please copy the URL and add it into your RSS Feed Reader.

Facebook Linkedin Weibo

Synfacts 2022; 18(09): 1032
DOI: 10.1055/s-0041-1738302

Innovative Drug Discovery and Development

Contributor(s):

Antonia F. Stepan (Roche)

,

Nadine Kuhl (Merck Sharp & Dohme)

Key words

structure–activity relationship - ATP competitive Akt inhibitors - cancer therapy - antitumor drugs - enzyme inhibitors

Article published online:
18 August 2022

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany